Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 59 of the 66 references it cites were found in a registry or an index; 7 of the 14 sources its claims cite were checked for support.

Diagnostic Significance of Selected Serum Inflammatory Markers in Women with Advanced Endometriosis

Open access
Kokot, Izabela, Piwowar, Agnieszka, Jędryka, Marcin, Sołkiewicz, Katarzyna, Kratz, Ewa Maria · 2021 · International Journal of Molecular Sciences

Abstract

Endometriosis is a gynecological disease, the pathogenesis of which seems to be directly associated with inflammatory processes. Serum concentrations of IL-1β, IL-6, hs-CRP, IgG, YKL 40 and PRL, in comparison to the well-known CA 125 levels, were studied with the aim of identifying an additional noninvasive inflammatory marker or set of markers characteristic for endometriosis. The study group included 43 women with endometriosis (E), 35 women with benign gynecological disorders but without endometriosis (NE, non-endometriosis) as a comparative group, and a control group consisting of 18 healthy subjects (C). The serum concentrations of IL-1β, IL-6, hs-CRP, YKL-40, PRL and CA 125 were significantly higher in the E group (median values: 0.41 pg/mL, 2.42 pg/mL, 2.33 mg/L, 79.30 ng/mL, 21.88 ng/mL and 68.00 U/mL, respectively) than in the control group (median values: 0.21 pg/mL, 0.98 pg/mL, 0.52 mg/L, 49.77 ng/mL, 12.08 ng/mL and 12.20 U/mL respectively), with the significance of p = 0.011, p < 0.001, p = 0.028, p = 0.005, p < 0.001 and p < 0.001, respectively. The IgG concentrations were significantly lower in the endometriosis group (median value: 1061.21 mg/dL) as compared to healthy women (median value: 1210.50 mg/dL; p = 0.025). Significant differences in concentrations of IL-6 (p = 0.040), hs-CRP (p = 0.007) and CA 125 (p < 0.001) were observed in stage III vs. stage IV of endometriosis. Significantly higher concentrations of IL-6 (p = 0.010), hs-CRP (p = 0.037) and PRL (p < 0.001) were observed in the NE group vs. the control group. Only CA 125 concentrations were significantly higher in endometriosis patients as compared to the non-endometriosis group (p < 0.001). The proposed panel of inflammatory markers, especially IL-6, PRL and CA 125, may become a useful tool to identify women with advanced endometriosis who could qualify for treatment.

Overview

CoChat Summary

## TL;DR

This study measured serum inflammatory markers in women with advanced endometriosis, women with benign gynecological disease but no endometriosis, and healthy controls to assess noninvasive diagnostic value. IL-6, PRL, and especially CA 125 emerged as the most promising markers, with CA 125 showing the strongest ROC performance (AUC 0.964).

## Key findings

  • In the endometriosis group (n = 43), serum IL-1β, IL-6, hs-CRP, YKL-40, PRL, and CA 125 were all significantly higher than in healthy controls (n = 18), with median values of 0.41 vs 0.21 pg/mL, 2.42 vs 0.98 pg/mL, 2.33 vs 0.52 mg/L, 79.30 vs 49.77 ng/mL, 21.88 vs 12.08 ng/mL, and 68.00 vs 12.20 U/mL, respectively.
  • Compared with the non-endometriosis group (n = 35), only CA 125 was significantly higher in endometriosis (68.00 vs 14.99 U/mL; p < 0.001); IL-6, hs-CRP, IgG, YKL-40, and PRL did not differ significantly between those two groups.
  • ROC results in endometriosis vs controls showed: IL-1β AUC 0.708, IL-6 AUC 0.784, hs-CRP AUC 0.680, IgG AUC 0.685, YKL-40 AUC 0.736, PRL AUC 0.785, and CA 125 AUC 0.964; reported cut-offs included IL-6 at 2.20 pg/mL, PRL at 19.35 ng/mL, and CA 125 at 20.00 U/mL.
  • Within endometriosis, stage IV showed higher IL-6, hs-CRP, and CA 125 than stage III (p = 0.040, p = 0.007, and p < 0.001, respectively), and the cluster analysis using IL-6, PRL, and CA 125 separated one cluster containing all 18 healthy controls and only 6 endometriosis samples (15.4% of the endometriosis group).

## Methods

  • Serum samples were collected from 43 women with histologically confirmed endometriosis, 35 women with benign gynecological disorders without endometriosis, and 18 healthy reproductive-age women.
  • Endometriosis severity was classified by rAFS/ASRM staging; among the endometriosis patients, 20 had stage III and 23 had stage IV disease.
  • IL-1β, IL-6, and YKL-40 were measured by ELISA; hs-CRP and IgG by immunoturbidimetry; CA 125 and prolactin by analyzer-based assays. Statistical analysis included Shapiro–Wilk testing, Mann–Whitney tests, Spearman correlations, ROC curves, logistic regression, and cluster analysis.

## Limitations

  • The authors state there was a lack of a representative early-stage endometriosis group, limiting assessment of biomarkers for early disease.
  • They state that the broad range of concentration values affected statistical analysis and made conclusions difficult.
  • They state that peritoneal fluid was unavailable, preventing comparison with serum findings.
  • Evident from the text: the study is cross-sectional and compares groups at one time point, so it cannot establish causality or diagnostic performance beyond this sample.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/ijms22052295

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 The values of determined concentrations of IL-1β, IL-6, hs-CRP, IgG, YKL-40, PRL and CA 125 (A–G), respectively), (H) is the legend. E—endometriosis, NE—non-endometriosis groups. Control—group of healthy volunteers, III E and IV E—third and fourth stage of endometriosis, respectively. A two-tailed p-Value of less than 0.05 was considered significant.
Figure 1 The values of determined concentrations of IL-1β, IL-6, hs-CRP, IgG, YKL-40, PRL and CA 125 (A–G), respectively), (H) is the legend. E—endometriosis, NE—non-endometriosis groups. Control—group of healthy volunteers, III E and IV E—third and fourth stage of endometriosis, respectively. A two-tailed p-Value of less than 0.05 was considered significant.CC BY · PubMed Central
Figure 2 Receiver operating characteristic (ROC) curves for serum concentrations of IL-1β, IL-6, hs-CRP, IgG, YKL-40, PRL and CA 125 as markers of advanced endometriosis (A–H). Data are given as area under the ROC curve (AUC) with a 95% confidence interval.
Figure 2 Receiver operating characteristic (ROC) curves for serum concentrations of IL-1β, IL-6, hs-CRP, IgG, YKL-40, PRL and CA 125 as markers of advanced endometriosis (A–H). Data are given as area under the ROC curve (AUC) with a 95% confidence interval.CC BY · PubMed Central
Figure 3 Dendrogram of cluster analysis of serum IL-6, PRL and CA 125 expression for endometriosis and control groups. E—endometriosis, C—control group. The cluster analysis was performed only for parameters with the highest AUC value and for serum samples in which the concentrations of all three parameters were determined. Each serum sample is represented by a vector of three features: IL-6, PRL and CA 125. Cluster 5 and a cut-off lane separate 100% of women from the control group and 15.4% of endometriosis patients from the rest of the endometriosis samples (Clusters 1–4).
Figure 3 Dendrogram of cluster analysis of serum IL-6, PRL and CA 125 expression for endometriosis and control groups. E—endometriosis, C—control group. The cluster analysis was performed only for parameters with the highest AUC value and for serum samples in which the concentrations of all three parameters were determined. Each serum sample is represented by a vector of three features: IL-6, PRL and CA 125. Cluster 5 and a cut-off lane separate 100% of women from the control group and 15.4% of endometriosis patients from the rest of the endometriosis samples (Clusters 1–4).CC BY · PubMed Central

Verification

Claims the paper makes

7 Valid · 0 Not valid · 5 Not checked · 73 Own results and interpretations

52 more claims

Create a free account to see all 85 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 10
  • It may state two separate claims as one. 22
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 66 references

Cited by

See all 76

Metadata

Authors
Kokot, I., Piwowar, A., Jędryka, M., Sołkiewicz, K., & Kratz, E. M.
Affiliations
Wroclaw Medical University (PL)
Corresponding author
Kokot, Izabela
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2021-02-25
Volume
22
Issue
5
Pages
2295
ISSN
1422-0067 (ISSN-L)
OpenAlex
W3132403037
Cited by
76
References
66
Citations by year
2026: 13 · 2025: 15 · 2024: 16 · 2023: 9 · 2022: 14 · 2021: 8
FWCI
10.13
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Polish Ministry of Science and Higher Education (Grant for Young Scientists; SIMPLE System No: STM.D270.20.134)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
  • Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
Keywords
serum inflammatory markers, interleukin-6, IL-1β, high-sensitivity C-reactive protein, YKL-40, prolactin, IgG, CA125, non-invasive biomarkers, endometriosis stage, women's health
MeSH terms
Chitinase-3-Like Protein 1, Adult, C-Reactive Protein, Endometriosis, Female, Humans, Inflammation, Middle Aged, Receptors, Prolactin, ROC Curve, Biomarkers, Interleukin-6, Cluster Analysis, CA-125 Antigen, Interleukin-1beta

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Diagnostic Significance of Selected Serum Inflammatory Markers in Women with Advanced Endometriosis. https://app.cochat.ai/papers/10.3390/ijms22052295
The paper
Kokot, I., Piwowar, A., Jędryka, M., Sołkiewicz, K., & Kratz, E. M. (2021). Diagnostic Significance of Selected Serum Inflammatory Markers in Women with Advanced Endometriosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms22052295

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.